{"ticker": {"uuid": "21f8b12f-aa0b-414c-bdc1-ca44074d3755", "symbol": "CARL", "name": "Carlsmed, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m", "summary": "The article discusses the investment performance of insiders at Carlsmed, noting a collective loss of US$1.7 million despite a recent positive stock performance. It highlights that insiders bought shares at an average price of US$13.43 and the current price is US$3.88, indicating", "url": "https://news.futunn.com/en/post/75269601/possible-turnaround-for-carlsmed-insiders-still-down-us-1-7m", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-07T02:39:36", "published_display": "07 Jul 2026 02:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL - Carlsmed Inc Revenue Breakdown", "summary": "This article provides a detailed financial breakdown of Carlsmed Inc. (CARL), including its latest stock performance, market capitalization, revenue, income, and various financial ratios. It also lists insider and institutional ownership, analyst recommendations, and key performa", "url": "https://finviz.com/stock?t=CARL&ty=rv&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-01T23:10:45", "published_display": "01 Jul 2026 23:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham Initiates Carlsmed(CARL.US) With Buy Rating, Announces Target Price $17", "summary": "Needham has initiated coverage of Carlsmed (CARL.US) with a Buy rating. The firm has set a target price of $17 for the company's stock, indicating a positive outlook for its future performance.", "url": "https://www.moomoo.com/news/post/72327218/needham-initiates-carlsmed-carlus-with-buy-rating-announces-target-price", "source_name": "Moomoo", "published_at": "2026-07-01T12:12:35", "published_display": "01 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (NasdaqGS:CARL) Stock Forecast & Analyst Predictions", "summary": "Carlsmed (NasdaqGS:CARL) is forecasted to increase earnings by 2.2% and revenue by 33.7% per annum. The company has raised its earnings guidance multiple times for both 2025 and 2026, anticipating significant revenue growth. Recent updates include reporting higher-than-expected Q", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-carl/carlsmed/future", "source_name": "Simply Wall Street", "published_at": "2026-07-01T12:12:35", "published_display": "01 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Carlsmed, Inc. (CARL) stock, including analyst price targets, historical performance, earnings information, and financial data. Five analysts offer a 1-year price forecast, with current stock performance showing recent increases but a year-ove", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T00:09:19", "published_display": "27 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL)", "summary": "Carlsmed, Inc. (NASDAQ:CARL) stock is currently trading at $11.76, having shown recent fluctuations with a weekly rise of 13.54% and a monthly fall of 3.45%. Analysts forecast a price range between $16.00 and $23.00, and the company is expected to report earnings on August 27, 20", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:09:19", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Carlsmed, Inc. \u2013 NASDAQ:CARL", "summary": "This article provides key financial information for Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its enterprise value to forward revenue. It highlights the company's stock market presence on Nasdaq and offers an overview of its financials, news, and community data thro", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T20:39:45", "published_display": "26 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (DUS:I82)", "summary": "This article provides an overview of Carlsmed, Inc. (DUS:I82) stock, including its financial actuals and estimates. It covers details like analyst forecasts, historical price performance, upcoming earnings dates, and key financial metrics such as revenue, net income, and EBITDA. ", "url": "https://www.tradingview.com/symbols/DUS-I82/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:40:56", "published_display": "26 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Carlsmed, Inc. \u2013 NASDAQ:CARL", "summary": "This article provides a financial snapshot of Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication, with no trades occurring. The content is primarily a data placeholder from T", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:56", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This article provides a brief financial overview of Carlsmed, Inc. (LSX:A41CM7) focusing on its enterprise value to revenue forward metric. The information is presented within the TradingView platform, noting that the market is currently closed.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:09:19", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This page provides financial data, specifically the Enterprise Value to EBITDA forward, for Carlsmed, Inc. (A41CM7) traded on the Lang & Schwarz Exchange. The content is primarily a data page from TradingView, offering an overview of the company's financial performance.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:40:23", "published_display": "26 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7)", "summary": "This article provides an overview of Carlsmed, Inc. (LSX: A41CM7) focusing on its financial actuals, estimates, and stock performance. It includes details such as the current stock price, market capitalization, volatility, revenue, earnings, and analyst forecasts for its future p", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:10:55", "published_display": "25 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This article provides the \"Price to earnings forward\" value for Carlsmed, Inc. (LSX:A41CM7) on the Lang & Schwarz Exchange. It indicates that the market is currently closed with no trades. The article also includes general information about TradingView's platform and its various ", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T12:10:56", "published_display": "25 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23", "summary": "BTIG has reiterated its Buy rating on Carlsmed (CARL.US) and maintained its price target of $23. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/71920687/btig-maintains-carlsmed-carlus-with-buy-rating-maintains-target-price", "source_name": "Moomoo", "published_at": "2026-06-24T21:09:21", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] CARLSMED, INC. Insider Trading Activity", "summary": "CARLSMED, INC. director Kevin C. O\u2019Boyle was granted 13,698 shares of Common Stock as a stock award with no cash price per share. Following this transaction, he directly holds 31,031 common shares. These restricted stock units (RSUs) vest in full on the earlier of the day before ", "url": "https://www.stocktitan.net/sec-filings/CARL/form-4-carlsmed-inc-insider-trading-activity-04462d02d223.html", "source_name": "Stock Titan", "published_at": "2026-06-22T14:12:48", "published_display": "22 Jun 2026 14:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Carlsmed Ord Shs (CARL), detailing analyst ratings and growth estimates. Based on 5 analysts, the stock has a \"Buy\" rating with an average target price of $18.40, representing a 74.08% upside. The article also provides expected reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-carl/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:09:51", "published_display": "18 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL - Carlsmed Inc Stock Price and Quote", "summary": "This page provides a detailed financial overview of Carlsmed Inc. (CARL), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists recent news, analyst ratings, and insider trading activity for the company.", "url": "https://finviz.com/stock?t=CARL", "source_name": "Finviz", "published_at": "2026-06-01T22:09:52", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Cash Flow \u2013 LSX:A41CM7", "summary": "This article provides key cash flow information for Carlsmed, Inc. (LSX:A41CM7), highlighting its free cash flow and operating cash flow figures. For Q1 2026, the company reported a free cash flow of -11.33 million EUR, while for 2025, it was -25.22 million EUR with operating cas", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-28T20:39:37", "published_display": "28 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SY - So-Young International Inc ADR Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiQ0FVX3lxTE5aVlF6Vm5XckRQTHFUN05wVWlybzI4Mk13c25jSlJRd2RUWDdzdlFyRXkyUHV5TDRydjNIQWxaNU1ESnc?oc=5", "source_name": "Finviz", "published_at": "2026-05-27T01:04:55+00:00", "published_display": "27 May 2026 01:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUld6a1pEZENZSmd1MFJSUWs3YW1Kdnc1R2dvSEtOQ21pZjQ2MGRRUFFzeVE3YldpbDd0eTJTNzR2RjUtY3VBbVJPNUEzbm9sNy1tajdBWERXSTJrRkNKLW00LXBNSDh3THN0V3N1Y0tRZ1libFVkbXBXWkhOVWN4a21mcUNIS29uVzM0YWE5Mk5jUS1XdWNr?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/align-technology-algn-stock-outpacing-134002358.html", "source_name": "Zacks", "published_at": "2026-05-22T13:40:02+00:00", "published_display": "22 May 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to cash flow ratio of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "The article focuses on the price to cash flow ratio of Carlsmed, Inc. (LSX:A41CM7), indicating that this financial metric is accessible via TradingView. It appears to be a stub or a section of a larger financial data platform, providing an overview of where such information can b", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/price-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-14T07:10:04", "published_display": "14 May 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVR Energy (CVI): Carl C. Icahn Has A Bullish View on This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1HczRkQ3BHVmg0NFBrajc3SDBGSldLREl1dVJuQ3NsMThZZmU3RWllT2ZlZE16blJZbUZOLTh4ZlJTWm9zUkhHdE4xQ2h3cVNuVTFFSWlkYm9QaG9LMGdvM25tbjVPeDcwdFBhMXBKMHM1eU54X3c?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Monro Inc. (MNRO): Carl C. Icahn Is Loading Up on This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE16TXp4Q29EZ0dWSmg4SWpkUVZHNFplTnp6LVQ1U1NXX0dCZmwzc3pvWkNjV0t2enNlclQ5bVNRREVqNXdQQjNhTzBoVi01MW9MOHVPLXQwSVdrdzlOV2g5dllEdEhoeXVHMDN0bUtGdXhDWDBRUXc?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Centuri Holdings (CTRI): Carl C. Icahn Is Buying This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1rTmZCM3F4eXpOYndfZnZUQXNHZHE1S29QcE1XVlZCMWtDMUFHTHdhaVdlOXFJT3MwOUJDcVdEbEFvRG9jamxVcENnU0UwNThMbU04WEQ0ZTdYeDNQRU1sa0VwbldoT2RrZ0IyWDJ4MHB6ODlycG04dXVJdjdQNlU?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total equity of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "The article presents financial information for Carlsmed, Inc. (LSX:A41CM7) on TradingView, specifically focusing on its total equity. It indicates that the market is closed and provides an overview of available financial data. The content is primarily a data display page with var", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-balance-sheet/total-equity/", "source_name": "TradingView", "published_at": "2026-05-13T01:09:11", "published_display": "13 May 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Return on equity % of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This page on TradingView provides financial information for Carlsmed, Inc. (LSX:A41CM7), specifically focusing on its Return on Equity percentage. It presents market data and financial metrics for the company.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/return-on-equity/", "source_name": "TradingView", "published_at": "2026-05-12T21:39:48", "published_display": "12 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Income Statement \u2013 LSX:A41CM7", "summary": "This article presents the income statement for Carlsmed, Inc. (LSX:A41CM7), detailing its financial performance. The company reported a total revenue of \u20ac13.95 million for the last quarter, an 8.03% increase from the previous quarter, with a net income of -\u20ac7.53 million for Q1 20", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-income-statement/", "source_name": "TradingView", "published_at": "2026-05-12T15:39:48", "published_display": "12 May 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Carl Zeiss Meditec stock surging today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQM1dxczRJZ0VuYUd1ZlNUWkRXS1pZdjVSZzMyRTl6SklVU1dHRm5NNmNfaDFxNTl1LUZuajJUSjBCMGFYdUFIdUlMVVo5S3Fic2NWSkhJRE1GbkdPRDBLNzRWT0JzT3NGYks5eUxuZ3FFS1F1TkFZTjdnUWRqOVNuaGowU0xGOV9NWjJJTklRbXF6WE1mWEZXclJ1SGhDWU04enBLOHFPN2laZDA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total liabilities of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article provides a brief financial overview of Carlsmed, Inc. (LS:A41CM7) on TradingView, specifically focusing on its total liabilities. It indicates that comprehensive market data is sourced from ICE Data Services and FactSet, with SEC filings from Quartr. Users are direct", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-balance-sheet/total-liabilities/", "source_name": "TradingView", "published_at": "2026-05-11T13:39:45", "published_display": "11 May 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA ratio of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article displays the enterprise value to EBITDA ratio for Carlsmed, Inc. under its stock symbol LS:A41CM7 on TradingView. It provides financial overview, news, and community features related to the company's stock. The data is sourced from ICE Data Services, FactSet, and Qua", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/enterprise-value-ebitda/", "source_name": "TradingView", "published_at": "2026-05-11T13:39:45", "published_display": "11 May 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating expenses (excl. COGS) of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article provides financial data specifically on the operating expenses (excluding Cost of Goods Sold) of Carlsmed, Inc. (LS:A41CM7). It appears to be a snapshot from a financial data platform, highlighting the company's financial performance in this particular area. The cont", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/operating-expenses/", "source_name": "TradingView", "published_at": "2026-05-11T12:40:21", "published_display": "11 May 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Debt to equity ratio of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "The article focuses on the debt to equity ratio of Carlsmed, Inc. (LS:A41CM7), indicating that financial data points from ICE Data Services and FactSet are used. It presents a financial overview for the company, accessible through TradingView.", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/debt-to-equity/", "source_name": "TradingView", "published_at": "2026-05-11T12:38:45", "published_display": "11 May 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total operating expenses of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "The article provides financial information for Carlsmed, Inc. (LS:A41CM7) on TradingView. It shows the total operating expenses for the company, accessible through various financial data providers like ICE Data Services and FactSet. The content primarily focuses on the display of", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/total-oper-expense/", "source_name": "TradingView", "published_at": "2026-05-11T12:09:27", "published_display": "11 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Statistics \u2013 LS:A41CM7", "summary": "This page provides financial statistics for Carlsmed, Inc. (LS:A41CM7), a company listed on the Lang & Schwarz Tradecenter. It details various annual and quarterly key financial stats and ratios, including valuation, profitability, liquidity, solvency ratios, and per-share metric", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-05-11T12:09:27", "published_display": "11 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total revenue of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article focuses on the total revenue of Carlsmed, Inc. (LS:A41CM7) as presented on TradingView. It appears to be a financial data page rather than a detailed news article, providing context for the stock within the Technology Services sector.", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/total-revenue/", "source_name": "TradingView", "published_at": "2026-05-11T02:08:51", "published_display": "11 May 2026 02:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-think-carlsmed-135505113.html", "source_name": "Zacks", "published_at": "2026-05-08T13:55:05+00:00", "published_display": "08 May 2026 13:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter Results", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-analysts-forecasting-carlsmed-inc-193439374.html", "source_name": "Simply Wall St.", "published_at": "2026-05-07T19:34:39+00:00", "published_display": "07 May 2026 19:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPMjN3bThBVjNjNkRTcnUzREJuLVUyYXV4dEIzTWgwV1AwT1RVOEFCNlk1a0VnX25OM2tBaV9BV3M2MjhmWVlzZXlUcGs4WXF6b05xUTRvMW9KVFRnTmpCTllIMEFzNWFqZlFwSlhwUkJyNVE5OHp5R3NVeFhyV1FnRkROaXc5YUYtZE9NQ0Riel9kWVgzN0xiOQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. To Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/carlsmed-inc-participate-upcoming-investor-200100906.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T20:01:00+00:00", "published_display": "28 Apr 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carl Zeiss Meditec Stock: Hitting The Bottom (OTCMKTS:CZMWF)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOeGx5RmRfcHFVWk9UaWZ1UDFoSHVTN0lFZGZkck9Dd0Mwek0wSXZXR2Ftc0NFSDRBbFNRLTlPeUYyZkRlTEtJUGprMFdjWmFZRTJ4Y1hYem9BUkJIQU1rMjRyUFNuYk5aYTBxUmUwaGtmcUVfYlhseUN2Y0JwQ05KVHNPcTI?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carl Icahn Keeps Buying Monro Stock After Poison Pill Move - Monro (NASDAQ:MNRO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOejJDVGRlOGIyT2JlSzVpQ2NNNEdzZWxzZmxBLVhtZ0ZlYXpGYTcySDAyRUVxRVp0OVkyMUtUMjNJX1IweWd4bGpDRHRRQnlzbzN6VDc1Q2F4UWk5Y2VyenhINmNUSkctcnRmYkFTOWMwZHgtMUdMeUVhNWVjTTAwbXZsUFFPUkFyNHoweGo1ZHB2TWR0Y1BBTUJmczNrRVM5ZjlGVHBfLUFvREVLVktKRzVSanFuaWxmWklEUmFNYUphQkJy?oc=5", "source_name": "Benzinga", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Workday stock drops 5%+ after CEO Carl Eschenbach steps down", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPVDBVZG1oOGNUdjgxZmtmcGlici1KVWlDUEdNTF9FVjNIbEduZHZDUko2VFUzV3pGcDBYbU15dmp5U2ozSm42eEc5Z2M4Z3o2bmdfc0RzZEdRZTVvZ05ZOThUcklEYUtWcDhMM2JKYS1DcTVNd1BBTmxQMFU0b1RZNkJJLThHYWpwd1h0ZA?oc=5", "source_name": "SiliconANGLE", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs downgrades Carl Zeiss Meditec stock to Neutral on headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNWjYwZTNvSmtpbEtXVVNwamxQR1RfTEliZXRSX3VOLW82TW1xUXJpNTl5dXQyaGlhTVBQNHdtNnNwVVh3Z1F3MG1pUURMRmpuclJhUEpoWDNtbG53Y2RsaWpQbjR1enF1WFN0c0pza19SYnRxdFl2SXp6MzV4WWlfQUZtdHZWTUhTTV9mUUQ2SnhaZGxmS0E5SVozbVRFZy1Mb3hPQjJjS21UNUN4bkZ1cjNpX0Z0dzJhcWlvLUZfdWQxYlVBMlRzQ1g0X0o2UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eco Science (ESSI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5pdzBTRmxWRF9FdWNNTm9zUHp3cGVyeUtkRjNscHJKRWx0cUNkb2t5VTVsNXBNNDBXb3l2Qko1OXo2NXRfc0E5SjlvTVRyLUoycmlv?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-18T22:26:50+00:00", "published_display": "18 Sep 2025 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Forecast and Price Target 2026 $CARL", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFA2LVI3SHhlSjZMTFNEanlLRVpGX25RWTVmbHhOM3FWZWV4eGNGVmtYSHY2aW1jaXRfclhmUlZ3c1puX19POTlhbFl0RFhVTi1PR0tONWR3RDNfblFxVEhZdl9mcG1VUQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-09-06T00:23:55+00:00", "published_display": "06 Sep 2025 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Price, News & Analysis $CARL", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5aZEhtaGdZSTBITDIxM0h4MWRvVzVSSzUxU0hTNU04WUNERmZjQTM1ZTN4TnNsa1VWal8wZmN4REZoT3pyYjV5RnFQTUttU3czeWdfVXN2MXNsZw?oc=5", "source_name": "MarketBeat", "published_at": "2025-09-06T00:23:43+00:00", "published_display": "06 Sep 2025 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Analysis Report | Ratings, Financials & Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9yZDVzSjY2QWd6c1BRYnA3R1BqaVp3bEVCSElOcmg4QVFhZFVyT0dOaXNzcW5ydC1rTWJUYjFKZTlyYW83UkFsRUFSQWF0aXh3YlJjWQ?oc=5", "source_name": "Benzinga", "published_at": "2025-08-18T13:07:54+00:00", "published_display": "18 Aug 2025 13:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5WVW9yeDgxTjI4cHdXSWtKWnRQeDdJakQwVnZzTlo3Vl9DSmpPM0ZVempnelFwWXZMRTNwVk5STWFpVzU5RWxVSzhvdlp1UEFL?oc=5", "source_name": "CNN", "published_at": "2025-07-16T19:18:57+00:00", "published_display": "16 Jul 2025 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Streamline Health Solutions In (STRM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2QmlFQ3laVE9oMXFKazhkeFZOM2FUQ0pGVUthUFlJRGQ3U1dkSXJmcXhoZXpfQi1JbTVJdEgtbmJZWVcyNVdENzNLZ21XOXdRZXhF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T04:54:57+00:00", "published_display": "25 Apr 2025 04:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TruBridge (TBRG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTeUEyaURoX1pUeXB4SEpSazZmal9VbGF2Qm8yWkVQZ2MwT3NzQTZkalRTRjdKcWM1YVA3TXpFOC1ZQ2lUWjdsM0QtNGFlNlhrLW1V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:29:21+00:00", "published_display": "25 Apr 2025 01:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0ydzh1bEdnSnNlUEItUk5hZ0dGaV9yS2dscmFDa2tpT1ZFaGkwbzhLdUt3N3pfTnpHRlNVNE85N2J3cm4yajI4Zk9YbFpObW5aSnJV?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T18:07:28+00:00", "published_display": "24 Apr 2025 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teladoc Health (TDOC) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB6cnZJRGVQQ2FEUWlfMmE1Y3dlcUg4NUpCbXhRTmFfSVVDenhNMVpvbllGV09jQ01XUFM5SHJONnZuQTN2TXlYREN6OWszaXBHMnI4?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:35:31+00:00", "published_display": "24 Apr 2025 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nVmdOdTFQYkVyaHJ6UW1DUWlITUZGdXlFY0l3dnZiNTk5djRlSFN0RFJkUHZ5RTMtU0VBMkJyZy1qb3ZsLUFyUmdFdWhiMDNaaVAw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:44+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WelBZRkpwbTJyZGN3RnVKTTJRU1BfbklLMDJvS1RNZVV0LWFKV001cGVpWFV4Q3FQOHpMaE11TkppelZrd0gxMkY1S1FFWklWMFo4?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:25:32+00:00", "published_display": "24 Apr 2025 17:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m", "summary": "The article discusses the investment performance of insiders at Carlsmed, noting a collective loss of US$1.7 million despite a recent positive stock performance. It highlights that insiders bought shares at an average price of US$13.43 and the current price is US$3.88, indicating", "url": "https://news.futunn.com/en/post/75269601/possible-turnaround-for-carlsmed-insiders-still-down-us-1-7m", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-07T02:39:36", "published_display": "07 Jul 2026 02:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL - Carlsmed Inc Revenue Breakdown", "summary": "This article provides a detailed financial breakdown of Carlsmed Inc. (CARL), including its latest stock performance, market capitalization, revenue, income, and various financial ratios. It also lists insider and institutional ownership, analyst recommendations, and key performa", "url": "https://finviz.com/stock?t=CARL&ty=rv&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-01T23:10:45", "published_display": "01 Jul 2026 23:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham Initiates Carlsmed(CARL.US) With Buy Rating, Announces Target Price $17", "summary": "Needham has initiated coverage of Carlsmed (CARL.US) with a Buy rating. The firm has set a target price of $17 for the company's stock, indicating a positive outlook for its future performance.", "url": "https://www.moomoo.com/news/post/72327218/needham-initiates-carlsmed-carlus-with-buy-rating-announces-target-price", "source_name": "Moomoo", "published_at": "2026-07-01T12:12:35", "published_display": "01 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (NasdaqGS:CARL) Stock Forecast & Analyst Predictions", "summary": "Carlsmed (NasdaqGS:CARL) is forecasted to increase earnings by 2.2% and revenue by 33.7% per annum. The company has raised its earnings guidance multiple times for both 2025 and 2026, anticipating significant revenue growth. Recent updates include reporting higher-than-expected Q", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-carl/carlsmed/future", "source_name": "Simply Wall Street", "published_at": "2026-07-01T12:12:35", "published_display": "01 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Carlsmed, Inc. (CARL) stock, including analyst price targets, historical performance, earnings information, and financial data. Five analysts offer a 1-year price forecast, with current stock performance showing recent increases but a year-ove", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T00:09:19", "published_display": "27 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (NASDAQ:CARL)", "summary": "Carlsmed, Inc. (NASDAQ:CARL) stock is currently trading at $11.76, having shown recent fluctuations with a weekly rise of 13.54% and a monthly fall of 3.45%. Analysts forecast a price range between $16.00 and $23.00, and the company is expected to report earnings on August 27, 20", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T21:09:19", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Carlsmed, Inc. \u2013 NASDAQ:CARL", "summary": "This article provides key financial information for Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its enterprise value to forward revenue. It highlights the company's stock market presence on Nasdaq and offers an overview of its financials, news, and community data thro", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T20:39:45", "published_display": "26 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (DUS:I82)", "summary": "This article provides an overview of Carlsmed, Inc. (DUS:I82) stock, including its financial actuals and estimates. It covers details like analyst forecasts, historical price performance, upcoming earnings dates, and key financial metrics such as revenue, net income, and EBITDA. ", "url": "https://www.tradingview.com/symbols/DUS-I82/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:40:56", "published_display": "26 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Carlsmed, Inc. \u2013 NASDAQ:CARL", "summary": "This article provides a financial snapshot of Carlsmed, Inc. (NASDAQ: CARL), specifically focusing on its forward price-to-sales ratio. It indicates that the market was closed at the time of publication, with no trades occurring. The content is primarily a data placeholder from T", "url": "https://www.tradingview.com/symbols/NASDAQ-CARL/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:56", "published_display": "26 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This article provides a brief financial overview of Carlsmed, Inc. (LSX:A41CM7) focusing on its enterprise value to revenue forward metric. The information is presented within the TradingView platform, noting that the market is currently closed.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T08:09:19", "published_display": "26 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This page provides financial data, specifically the Enterprise Value to EBITDA forward, for Carlsmed, Inc. (A41CM7) traded on the Lang & Schwarz Exchange. The content is primarily a data page from TradingView, offering an overview of the company's financial performance.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T07:40:23", "published_display": "26 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Actuals & Estimates (LSX:A41CM7)", "summary": "This article provides an overview of Carlsmed, Inc. (LSX: A41CM7) focusing on its financial actuals, estimates, and stock performance. It includes details such as the current stock price, market capitalization, volatility, revenue, earnings, and analyst forecasts for its future p", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T15:10:55", "published_display": "25 Jun 2026 15:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This article provides the \"Price to earnings forward\" value for Carlsmed, Inc. (LSX:A41CM7) on the Lang & Schwarz Exchange. It indicates that the market is currently closed with no trades. The article also includes general information about TradingView's platform and its various ", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T12:10:56", "published_display": "25 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains Carlsmed(CARL.US) With Buy Rating, Maintains Target Price $23", "summary": "BTIG has reiterated its Buy rating on Carlsmed (CARL.US) and maintained its price target of $23. This indicates a continued positive outlook from the firm regarding the company's stock performance.", "url": "https://www.moomoo.com/news/post/71920687/btig-maintains-carlsmed-carlus-with-buy-rating-maintains-target-price", "source_name": "Moomoo", "published_at": "2026-06-24T21:09:21", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] CARLSMED, INC. Insider Trading Activity", "summary": "CARLSMED, INC. director Kevin C. O\u2019Boyle was granted 13,698 shares of Common Stock as a stock award with no cash price per share. Following this transaction, he directly holds 31,031 common shares. These restricted stock units (RSUs) vest in full on the earlier of the day before ", "url": "https://www.stocktitan.net/sec-filings/CARL/form-4-carlsmed-inc-insider-trading-activity-04462d02d223.html", "source_name": "Stock Titan", "published_at": "2026-06-22T14:12:48", "published_display": "22 Jun 2026 14:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Carlsmed Ord Shs (CARL), detailing analyst ratings and growth estimates. Based on 5 analysts, the stock has a \"Buy\" rating with an average target price of $18.40, representing a 74.08% upside. The article also provides expected reven", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-carl/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:09:51", "published_display": "18 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARL - Carlsmed Inc Stock Price and Quote", "summary": "This page provides a detailed financial overview of Carlsmed Inc. (CARL), including its stock price, market capitalization, income, sales, and various financial ratios. It also lists recent news, analyst ratings, and insider trading activity for the company.", "url": "https://finviz.com/stock?t=CARL", "source_name": "Finviz", "published_at": "2026-06-01T22:09:52", "published_display": "01 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth Amidst Strong Revenue Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxORE9OaWtsRXhXVG1pb1k1OE55LTR4RXBWbUthTDBzSUMwdEZZcGdhUHNQdmFQeWIwbUlsYWNGZlVHVnNQTFF1Z0ZTUXBmME5tOVI1UjRtbTBkMC1Gc092TFRRUGpRaXJmMnhSTWRFS1FCYkIyeU1FbU5Hc1ZjOGtOZENWOUJuSEdjbGJIQjBPZmNhSy1GRVh1bTRDd0JKLWN3U0VoQi1YZEpjcTBKaUFvMzRxSENzUjdSR1VjT3o3V1gySXJXTHVTdzhzQ1NjWEMybnRNVHJIby1YanRt?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Cash Flow \u2013 LSX:A41CM7", "summary": "This article provides key cash flow information for Carlsmed, Inc. (LSX:A41CM7), highlighting its free cash flow and operating cash flow figures. For Q1 2026, the company reported a free cash flow of -11.33 million EUR, while for 2025, it was -25.22 million EUR with operating cas", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-28T20:39:37", "published_display": "28 May 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SY - So-Young International Inc ADR Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiQ0FVX3lxTE5aVlF6Vm5XckRQTHFUN05wVWlybzI4Mk13c25jSlJRd2RUWDdzdlFyRXkyUHV5TDRydjNIQWxaNU1ESnc?oc=5", "source_name": "Finviz", "published_at": "2026-05-27T01:04:55+00:00", "published_display": "27 May 2026 01:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUld6a1pEZENZSmd1MFJSUWs3YW1Kdnc1R2dvSEtOQ21pZjQ2MGRRUFFzeVE3YldpbDd0eTJTNzR2RjUtY3VBbVJPNUEzbm9sNy1tajdBWERXSTJrRkNKLW00LXBNSDh3THN0V3N1Y0tRZ1libFVkbXBXWkhOVWN4a21mcUNIS29uVzM0YWE5Mk5jUS1XdWNr?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/align-technology-algn-stock-outpacing-134002358.html", "source_name": "Zacks", "published_at": "2026-05-22T13:40:02+00:00", "published_display": "22 May 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to cash flow ratio of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "The article focuses on the price to cash flow ratio of Carlsmed, Inc. (LSX:A41CM7), indicating that this financial metric is accessible via TradingView. It appears to be a stub or a section of a larger financial data platform, providing an overview of where such information can b", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/price-cash-flow/", "source_name": "TradingView", "published_at": "2026-05-14T07:10:04", "published_display": "14 May 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVR Energy (CVI): Carl C. Icahn Has A Bullish View on This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE1HczRkQ3BHVmg0NFBrajc3SDBGSldLREl1dVJuQ3NsMThZZmU3RWllT2ZlZE16blJZbUZOLTh4ZlJTWm9zUkhHdE4xQ2h3cVNuVTFFSWlkYm9QaG9LMGdvM25tbjVPeDcwdFBhMXBKMHM1eU54X3c?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Monro Inc. (MNRO): Carl C. Icahn Is Loading Up on This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE16TXp4Q29EZ0dWSmg4SWpkUVZHNFplTnp6LVQ1U1NXX0dCZmwzc3pvWkNjV0t2enNlclQ5bVNRREVqNXdQQjNhTzBoVi01MW9MOHVPLXQwSVdrdzlOV2g5dllEdEhoeXVHMDN0bUtGdXhDWDBRUXc?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Centuri Holdings (CTRI): Carl C. Icahn Is Buying This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE1rTmZCM3F4eXpOYndfZnZUQXNHZHE1S29QcE1XVlZCMWtDMUFHTHdhaVdlOXFJT3MwOUJDcVdEbEFvRG9jamxVcENnU0UwNThMbU04WEQ0ZTdYeDNQRU1sa0VwbldoT2RrZ0IyWDJ4MHB6ODlycG04dXVJdjdQNlU?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total equity of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "The article presents financial information for Carlsmed, Inc. (LSX:A41CM7) on TradingView, specifically focusing on its total equity. It indicates that the market is closed and provides an overview of available financial data. The content is primarily a data display page with var", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-balance-sheet/total-equity/", "source_name": "TradingView", "published_at": "2026-05-13T01:09:11", "published_display": "13 May 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Return on equity % of Carlsmed, Inc. \u2013 LSX:A41CM7", "summary": "This page on TradingView provides financial information for Carlsmed, Inc. (LSX:A41CM7), specifically focusing on its Return on Equity percentage. It presents market data and financial metrics for the company.", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-statistics-and-ratios/return-on-equity/", "source_name": "TradingView", "published_at": "2026-05-12T21:39:48", "published_display": "12 May 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Income Statement \u2013 LSX:A41CM7", "summary": "This article presents the income statement for Carlsmed, Inc. (LSX:A41CM7), detailing its financial performance. The company reported a total revenue of \u20ac13.95 million for the last quarter, an 8.03% increase from the previous quarter, with a net income of -\u20ac7.53 million for Q1 20", "url": "https://www.tradingview.com/symbols/LSX-A41CM7/financials-income-statement/", "source_name": "TradingView", "published_at": "2026-05-12T15:39:48", "published_display": "12 May 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Carl Zeiss Meditec stock surging today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQM1dxczRJZ0VuYUd1ZlNUWkRXS1pZdjVSZzMyRTl6SklVU1dHRm5NNmNfaDFxNTl1LUZuajJUSjBCMGFYdUFIdUlMVVo5S3Fic2NWSkhJRE1GbkdPRDBLNzRWT0JzT3NGYks5eUxuZ3FFS1F1TkFZTjdnUWRqOVNuaGowU0xGOV9NWjJJTklRbXF6WE1mWEZXclJ1SGhDWU04enBLOHFPN2laZDA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total liabilities of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article provides a brief financial overview of Carlsmed, Inc. (LS:A41CM7) on TradingView, specifically focusing on its total liabilities. It indicates that comprehensive market data is sourced from ICE Data Services and FactSet, with SEC filings from Quartr. Users are direct", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-balance-sheet/total-liabilities/", "source_name": "TradingView", "published_at": "2026-05-11T13:39:45", "published_display": "11 May 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA ratio of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article displays the enterprise value to EBITDA ratio for Carlsmed, Inc. under its stock symbol LS:A41CM7 on TradingView. It provides financial overview, news, and community features related to the company's stock. The data is sourced from ICE Data Services, FactSet, and Qua", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/enterprise-value-ebitda/", "source_name": "TradingView", "published_at": "2026-05-11T13:39:45", "published_display": "11 May 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating expenses (excl. COGS) of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article provides financial data specifically on the operating expenses (excluding Cost of Goods Sold) of Carlsmed, Inc. (LS:A41CM7). It appears to be a snapshot from a financial data platform, highlighting the company's financial performance in this particular area. The cont", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/operating-expenses/", "source_name": "TradingView", "published_at": "2026-05-11T12:40:21", "published_display": "11 May 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Debt to equity ratio of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "The article focuses on the debt to equity ratio of Carlsmed, Inc. (LS:A41CM7), indicating that financial data points from ICE Data Services and FactSet are used. It presents a financial overview for the company, accessible through TradingView.", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/debt-to-equity/", "source_name": "TradingView", "published_at": "2026-05-11T12:38:45", "published_display": "11 May 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total operating expenses of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "The article provides financial information for Carlsmed, Inc. (LS:A41CM7) on TradingView. It shows the total operating expenses for the company, accessible through various financial data providers like ICE Data Services and FactSet. The content primarily focuses on the display of", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/total-oper-expense/", "source_name": "TradingView", "published_at": "2026-05-11T12:09:27", "published_display": "11 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. Statistics \u2013 LS:A41CM7", "summary": "This page provides financial statistics for Carlsmed, Inc. (LS:A41CM7), a company listed on the Lang & Schwarz Tradecenter. It details various annual and quarterly key financial stats and ratios, including valuation, profitability, liquidity, solvency ratios, and per-share metric", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-05-11T12:09:27", "published_display": "11 May 2026 12:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total revenue of Carlsmed, Inc. \u2013 LS:A41CM7", "summary": "This article focuses on the total revenue of Carlsmed, Inc. (LS:A41CM7) as presented on TradingView. It appears to be a financial data page rather than a detailed news article, providing context for the stock within the Technology Services sector.", "url": "https://www.tradingview.com/symbols/LS-A41CM7/financials-income-statement/total-revenue/", "source_name": "TradingView", "published_at": "2026-05-11T02:08:51", "published_display": "11 May 2026 02:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-think-carlsmed-135505113.html", "source_name": "Zacks", "published_at": "2026-05-08T13:55:05+00:00", "published_display": "08 May 2026 13:55", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter Results", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-analysts-forecasting-carlsmed-inc-193439374.html", "source_name": "Simply Wall St.", "published_at": "2026-05-07T19:34:39+00:00", "published_display": "07 May 2026 19:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPMjN3bThBVjNjNkRTcnUzREJuLVUyYXV4dEIzTWgwV1AwT1RVOEFCNlk1a0VnX25OM2tBaV9BV3M2MjhmWVlzZXlUcGs4WXF6b05xUTRvMW9KVFRnTmpCTllIMEFzNWFqZlFwSlhwUkJyNVE5OHp5R3NVeFhyV1FnRkROaXc5YUYtZE9NQ0Riel9kWVgzN0xiOQ?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed, Inc. To Participate in Upcoming Investor Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/carlsmed-inc-participate-upcoming-investor-200100906.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T20:01:00+00:00", "published_display": "28 Apr 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carl Zeiss Meditec Stock: Hitting The Bottom (OTCMKTS:CZMWF)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOeGx5RmRfcHFVWk9UaWZ1UDFoSHVTN0lFZGZkck9Dd0Mwek0wSXZXR2Ftc0NFSDRBbFNRLTlPeUYyZkRlTEtJUGprMFdjWmFZRTJ4Y1hYem9BUkJIQU1rMjRyUFNuYk5aYTBxUmUwaGtmcUVfYlhseUN2Y0JwQ05KVHNPcTI?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carl Icahn Keeps Buying Monro Stock After Poison Pill Move - Monro (NASDAQ:MNRO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOejJDVGRlOGIyT2JlSzVpQ2NNNEdzZWxzZmxBLVhtZ0ZlYXpGYTcySDAyRUVxRVp0OVkyMUtUMjNJX1IweWd4bGpDRHRRQnlzbzN6VDc1Q2F4UWk5Y2VyenhINmNUSkctcnRmYkFTOWMwZHgtMUdMeUVhNWVjTTAwbXZsUFFPUkFyNHoweGo1ZHB2TWR0Y1BBTUJmczNrRVM5ZjlGVHBfLUFvREVLVktKRzVSanFuaWxmWklEUmFNYUphQkJy?oc=5", "source_name": "Benzinga", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Workday stock drops 5%+ after CEO Carl Eschenbach steps down", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPVDBVZG1oOGNUdjgxZmtmcGlici1KVWlDUEdNTF9FVjNIbEduZHZDUko2VFUzV3pGcDBYbU15dmp5U2ozSm42eEc5Z2M4Z3o2bmdfc0RzZEdRZTVvZ05ZOThUcklEYUtWcDhMM2JKYS1DcTVNd1BBTmxQMFU0b1RZNkJJLThHYWpwd1h0ZA?oc=5", "source_name": "SiliconANGLE", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Goldman Sachs downgrades Carl Zeiss Meditec stock to Neutral on headwinds", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNWjYwZTNvSmtpbEtXVVNwamxQR1RfTEliZXRSX3VOLW82TW1xUXJpNTl5dXQyaGlhTVBQNHdtNnNwVVh3Z1F3MG1pUURMRmpuclJhUEpoWDNtbG53Y2RsaWpQbjR1enF1WFN0c0pza19SYnRxdFl2SXp6MzV4WWlfQUZtdHZWTUhTTV9mUUQ2SnhaZGxmS0E5SVozbVRFZy1Mb3hPQjJjS21UNUN4bkZ1cjNpX0Z0dzJhcWlvLUZfdWQxYlVBMlRzQ1g0X0o2UQ?oc=5", "source_name": "Investing.com", "published_at": "2026-01-20T08:00:00+00:00", "published_display": "20 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eco Science (ESSI) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5pdzBTRmxWRF9FdWNNTm9zUHp3cGVyeUtkRjNscHJKRWx0cUNkb2t5VTVsNXBNNDBXb3l2Qko1OXo2NXRfc0E5SjlvTVRyLUoycmlv?oc=5", "source_name": "Stock Titan", "published_at": "2025-09-18T22:26:50+00:00", "published_display": "18 Sep 2025 22:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Forecast and Price Target 2026 $CARL", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFA2LVI3SHhlSjZMTFNEanlLRVpGX25RWTVmbHhOM3FWZWV4eGNGVmtYSHY2aW1jaXRfclhmUlZ3c1puX19POTlhbFl0RFhVTi1PR0tONWR3RDNfblFxVEhZdl9mcG1VUQ?oc=5", "source_name": "MarketBeat", "published_at": "2025-09-06T00:23:55+00:00", "published_display": "06 Sep 2025 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Price, News & Analysis $CARL", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5aZEhtaGdZSTBITDIxM0h4MWRvVzVSSzUxU0hTNU04WUNERmZjQTM1ZTN4TnNsa1VWal8wZmN4REZoT3pyYjV5RnFQTUttU3czeWdfVXN2MXNsZw?oc=5", "source_name": "MarketBeat", "published_at": "2025-09-06T00:23:43+00:00", "published_display": "06 Sep 2025 00:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carlsmed (CARL) Stock Analysis Report | Ratings, Financials & Performance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE9yZDVzSjY2QWd6c1BRYnA3R1BqaVp3bEVCSElOcmg4QVFhZFVyT0dOaXNzcW5ydC1rTWJUYjFKZTlyYW83UkFsRUFSQWF0aXh3YlJjWQ?oc=5", "source_name": "Benzinga", "published_at": "2025-08-18T13:07:54+00:00", "published_display": "18 Aug 2025 13:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE5WVW9yeDgxTjI4cHdXSWtKWnRQeDdJakQwVnZzTlo3Vl9DSmpPM0ZVempnelFwWXZMRTNwVk5STWFpVzU5RWxVSzhvdlp1UEFL?oc=5", "source_name": "CNN", "published_at": "2025-07-16T19:18:57+00:00", "published_display": "16 Jul 2025 19:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Streamline Health Solutions In (STRM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB2QmlFQ3laVE9oMXFKazhkeFZOM2FUQ0pGVUthUFlJRGQ3U1dkSXJmcXhoZXpfQi1JbTVJdEgtbmJZWVcyNVdENzNLZ21XOXdRZXhF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T04:54:57+00:00", "published_display": "25 Apr 2025 04:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TruBridge (TBRG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBTeUEyaURoX1pUeXB4SEpSazZmal9VbGF2Qm8yWkVQZ2MwT3NzQTZkalRTRjdKcWM1YVA3TXpFOC1ZQ2lUWjdsM0QtNGFlNlhrLW1V?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T01:29:21+00:00", "published_display": "25 Apr 2025 01:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VSee Health (VSEE) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE0ydzh1bEdnSnNlUEItUk5hZ0dGaV9yS2dscmFDa2tpT1ZFaGkwbzhLdUt3N3pfTnpHRlNVNE85N2J3cm4yajI4Zk9YbFpObW5aSnJV?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T18:07:28+00:00", "published_display": "24 Apr 2025 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teladoc Health (TDOC) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFB6cnZJRGVQQ2FEUWlfMmE1Y3dlcUg4NUpCbXhRTmFfSVVDenhNMVpvbllGV09jQ01XUFM5SHJONnZuQTN2TXlYREN6OWszaXBHMnI4?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:35:31+00:00", "published_display": "24 Apr 2025 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Health Catalyst (HCAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9nVmdOdTFQYkVyaHJ6UW1DUWlITUZGdXlFY0l3dnZiNTk5djRlSFN0RFJkUHZ5RTMtU0VBMkJyZy1qb3ZsLUFyUmdFdWhiMDNaaVAw?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:33:44+00:00", "published_display": "24 Apr 2025 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrightSpring Health Services (BTSG) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1WelBZRkpwbTJyZGN3RnVKTTJRU1BfbklLMDJvS1RNZVV0LWFKV001cGVpWFV4Q3FQOHpMaE11TkppelZrd0gxMkY1S1FFWklWMFo4?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:25:32+00:00", "published_display": "24 Apr 2025 17:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 95, "total_relevant": 63, "sentiment_summary": {"positive": 13, "negative": 1, "neutral": 49, "score": 54, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 20.3, "count": 35}, {"event": "earnings", "label": "Earnings", "weight": 10.05, "count": 17}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.75, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}], "positive_events": 13, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 11.9, "latest_week": "2026-07-10", "one_week_move": 4.9, "four_week_move": 4.2, "twelve_week_move": 8.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.514357, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -3.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 39.1791, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.9% over one week, +4.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 21}, {"label": "Stock Titan", "count": 8}, {"label": "Market source", "count": 5}, {"label": "Finviz", "count": 3}, {"label": "Moomoo", "count": 2}, {"label": "Zacks", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Seeking Alpha", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 63}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 35}, {"label": "Earnings", "count": 17}, {"label": "Balance sheet", "count": 5}, {"label": "Analyst action", "count": 4}, {"label": "Guidance", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "63", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.9% over one week, +4.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m"}], "updated_at": "2026-07-16T05:13:53.725695+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}